N-[(1H-1,2,3-Benzotriazol-1-yl)methyl]-4-bromo-3-methylaniline

Catalog No. :
ACEGXC880
CAS No. :
256521-68-3
Molecular Formula :
C14H13BrN4
Molecular Weight :
317.19

IUPAC Name:N-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)-4-bromo-3-methylaniline

N-[(1H-1,2,3-Benzotriazol-1-yl)methyl]-4-bromo-3-methylaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[(1H-1,2,3-Benzotriazol-1-yl)methyl]-4-bromo-3-methylaniline
IUPAC NameN-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)-4-bromo-3-methylaniline
MDL No.MFCD00829648
Molecular FormulaC14H13BrN4
Molecular Weight317.19
SMILESCC1=CC(NCN2N=NC3=CC=CC=C32)=CC=C1Br
InChI KeyZVCUDKHYTYOHRV-UHFFFAOYSA-N
SynonymN-(1H-1,2,3-BENZOTRIAZOL-1-YLMETHYL)-N-(4-BROMO-3-METHYLPHENYL)AMINE;N-(1H-1,2,3-BENZOTRIAZOL-1-YLMETHYL)-4-BROMO-3-METHYLANILINE;1H-Benzotriazole-1-methanamine, N-(4-bromo-3-methylphenyl)-
CAS No.256521-68-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACEGXC880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBUXA750 route compound structure diagram
    ACBUXA7506933-10-4 In Stock
  2. Plus
  3. ACPMFB928 route compound structure diagram
    ACPMFB92872773-04-7 In Stock
  4. Then
  5. ACEGXC880 route product structure diagram
    ACEGXC880256521-68-3
Inquiry

2. ACEGXC880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBUXA750 route compound structure diagram
    ACBUXA7506933-10-4 In Stock
  2. Plus
  3. ACCYAB461 route compound structure diagram
    ACCYAB46128539-02-8 In Stock
  4. Then
  5. ACEGXC880 route product structure diagram
    ACEGXC880256521-68-3
Inquiry

Comments (0)